Skip to search formSkip to main contentSkip to account menu

Multiple Sclerosis, Chronic Progressive

Known as: Chronic Progressive Multiple Sclerosis, Multiple Sclerosis, Chronic Progressive [Disease/Finding] 
A form of multiple sclerosis characterized by a progressive deterioration in neurologic function which is in contrast to the more typical relapsing… 
National Institutes of Health

Related topics

Related topics

10 relations
In BloodMicrobiologicalchemically inducednursing therapy

Broader (1)

Multiple Sclerosis

Narrower (3)

Multiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Progressive RelapsingMultiple Sclerosis, Secondary Progressive

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Effect of intensive immunosuppression on the course of chronic progressive multiple sclerosis
Summary39 patients with chronic-progressive multiple sclerosis were treated with a short course of intensive immunosuppression… 
2002
2002
Acute interferon β-1b administration alters hypothalamic-pituitary-adrenal axis activity, plasma cytokines and leukocyte distribution in healthy subjects
Highly Cited
1996
Highly Cited
1996
Low-dose oral methotrexate in chronic progressive multiple sclerosis
We monitored 56 patients with chronic progressive multiple sclerosis (MS) who participated in a clinical trial of weekly, low… 
1996
1996
Characterization of Jc Virus Dna Amplified from Urine of Chronic Progressive Multiple Sclerosis Patients
Thirty-seven chronic progressive multiple sclerosis (MS) patients, 20 of whom were taking cyclosporine, were examined for… 
Highly Cited
1996
Highly Cited
1996
Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis
1995
1995
Meta‐analysis of clinical studies of the efficacy of plasma exchange in the treatment of chronic progressive multiple sclerosis
To examine the hypothesis that addition of therapeutic plasma exchange (TPEX) to an immunosuppressive drug regimen increases that… 
1991
1991
Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. II. Immunologic evaluation
Immunologic functions are studied in conjunction with a placebo-controlled trial of lymphoblastoid interferon (IFN) in patients… 
Highly Cited
1989
Highly Cited
1989
Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis
We measured levels of alpha–tumor necrosis factor (α‐TNF) in cerebrospinal fluid and serum samples from 50 drug‐free patients… 
Highly Cited
1983
Highly Cited
1983
Suppressor T‐lymphocytes in multiple sclerosis: Analysis of patients with acute relapsing and chronic progressive disease
T cell‐specific antigens as identified by the anti‐Leu 1, anti‐Leu 2a, and anti‐Leu 3a monoclonal antibodies were quantitated in… 
Highly Cited
1980
Highly Cited
1980
Plasmapheresis in multiple sclerosis
In six of eight patients with chronic progressive multiple sclerosis (MS) who were previously unresponsive to corticosteroid… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)